COVID-19, severe asthma, and biologics
Coronavirus disease 2019 (COVID-19) is an acute respiratory syndrome that emerged in the city of Wuhan and rapidly spread throughout the world causing a global pandemic.1 The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been identified as its causal agent.1 Factors such as older age or presence of comorbidities are frequently identified as variables with a negative effect on patients ’ prognosis.2 If we focus on the preexistent respiratory conditions, a higher risk of developing a severe infection has been reported in patients with chronic obstructive pulmonary disease.
Source: Annals of Allergy, Asthma and Immunology - Category: Allergy & Immunology Authors: Ismael Garc ía-Moguel, Rocío Díaz Campos, Sergio Alonso Charterina, Consuelo Fernández Rodríguez, Jesús Fernández Crespo Tags: Letters Source Type: research
More News: Allergy | Allergy & Immunology | Asthma | Chronic Obstructive Pulmonary | Coronavirus | COVID-19 | Pandemics | Respiratory Medicine | SARS